Genprex, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNPX research report →
About the company
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes.
- CEO
- Ryan Confer
- IPO
- 2018
- Employees
- 15
- HQ
- Austin, TX, US
Price Chart
- Market Cap
- $939.94K
- P/E
- -0.04
- P/S
- 0.00
- P/B
- 0.24
- EV/EBITDA
- 1.07
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -247.33%
- ROIC
- -94.62%
- Revenue
- $0 · 0.00%
- Net Income
- $-16,228,953 · 23.13%
- EPS
- $-17.40 · 93.48%
- Op Income
- $-15,515,619
- FCF YoY
- 10.72%
- 52W High
- $55.00
- 52W Low
- $0.42
- 50D MA
- $0.74
- 200D MA
- $3.57
- Beta
- -0.96
- Avg Volume
- 647.41K
Get TickerSpark's AI analysis on GNPX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 14, 26 | LONGNECKER BRENT M | sell | 8 |
| Apr 14, 26 | LONGNECKER BRENT M | sell | 10 |
| Feb 27, 26 | Berger Mark Stanley | other | 7,168 |
| Feb 27, 26 | Confer Ryan M. | other | 9,330 |
| Dec 22, 25 | Moreno Toscano Jose Antonio | other | 9,000 |
| Dec 22, 25 | Berger Mark Stanley | other | 28,500 |
| Dec 22, 25 | Confer Ryan M. | other | 45,000 |
| Dec 22, 25 | LONGNECKER BRENT M | other | 9,000 |
| Dec 22, 25 | Wilson William R Jr. | other | 9,000 |
| Jun 30, 25 | Berger Mark Stanley | other | 4,500 |
Our GNPX coverage
Recent articles, reports, and earnings notes.
No research on GNPX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GNPX report →Similar companies
Peers in the same neighborhood.